Cancer Management:A Multidisciplinary ApproachMedical, Surgical & Radiation OncologyContributors to Cancer Management:

Article

Contributors to Cancer Management:A Multidisciplinary ApproachMedical, Surgical & Radiation Oncology

Contributors

Thomas E. Ahlering, MD
Dennis S. Chi, MD
Steven R. Alberts, MD
Warren Chow, MD
Penny R. Anderson, MD
Lawrence R. Coia, MD
Kathleen W. Beekman, MD
Jay S. Cooper, MD
Al B. Benson III, MD
Jorge E. Cortes, MD
J. Sybil Biermann, MD
Jeffrey Crawford, MD
Charles D. Blanke, MD
Carey A. Cullinane, MD
Eduardo Bruera, MD
Lisa M. DeAngelis, MD
Mark Buyyounouski, MD
Lawrence Driver, MD
Emiliano Calvo, MD, PhD
Joshua D. I. Ellenhorn, MD

Carmen P. Escalante, MD
Steven M. Grunberg, MD
Andrew M. Evens, DO
Bruce G. Haffty, MD
Gilbert G. Fareau, MD
John Hoffman, MD
Paul Fisher, MD
Brent K. Hollenbeck, MD
Stephen J. Forman, MD
Eric M. Horwitz, MD
Michael J. Gazda, MS
William J. Hoskins, MD
Bonnie S. Glisson, MD
Mark Hurwitz, MD
Leo I. Gordon, MD
Maha Hussain, MD
Frederic W. Grannis, Jr., MD
Jimmy J. Hwang, MD
Kathryn M. Greven, MD
James Ito, Jr., MD

Rajesh V. Iyer, MD
Jeffrey P. Lamont, MD
Sundar Jagannath, MD
Rachelle M. Lanciano, MD
Ishmael Jaiyesimi, DO
Miriam N. Lango, MD
Lori Jardines, MD
Joseph Lattanzi, MD
Aminah Jatoi, MD
Alan List, MD
Eric H. Jensen, MD
Jay S. Loeffler, MD
Hagop Kantarjian, MD
Patrick J. Loehrer, MD
John J. Kavanagh, MD
Charles Loprinzi, MD
Kemp H. Kernstine, MD, PhD
Robert Lustig, MD
Fadlo R. Khuri, MD
Robert Maki, MD, PhD
Lily Lai, MD
Adam N. Mamelak, MD
Nicole Lamanna, MD
Gary N. Mann, MD

Ellen Manzullo, MD
Bert O’Neil, MD
Kim A. Margolin, MD
I. Benjamin Paz, MD
Maurie Markman, MD
Richard Pazdur, MD
David Scott Miller, MD
Carlos A. Perez, MD
Ronald T. Mitsuyasu, MD
Louis L. Pisters, MD
Judd W. Moul, MD
Peter W. T. Pisters, MD
Benjamin Movsas, MD
Stephen P. Povoski, MD
Nikhil C. Munshi, MD
Bruce G. Redman, DO
Robert J. Myerson, MD, PhD
Paul Richardson, MD
Nicos Nicolaou, MD
John Andrew Ridge, MD, PhD
Margaret R. O’Donnell, MD
John M. Robertson, MD

Steven T. Rosen, MD
David Straus, MD
Melanie Royce, MD, PhD
Chris H. Takimoto, MD, PhD
Stephen C. Rubin, MD
Alan Valentine, MD
Paul Sabbatini, MD
Rena Vassilopoulou-Sellin, MD
Roderich E. Schwarz, MD, PhD
Lawrence D. Wagman, MD
Walter Scott, MD
Sharon M. Weinstein, MD
Marisa Siebel, MD
Lawrence M. Weiss, MD
Richard T. Silver, MD
Mark A. Weiss, MD
Douglas Skarecky, BS
Mitchell Weiss, MD
Vernon K. Sondak, MD
Jeffrey Weitzel, MD
William G. Wierda, MD, PhD
Alan W. Yasko, MD
Jane N. Winter, MD
Sriram Yennurajalingam, MD
Joachim Yahalom, MD
Sally Yowell Barbour, PHARMD
Philippe E. Spiess, MD


 

Cara H. Glynn
Sr. Editorial Director
Angela Cibuls
Project Manager
Susan Reckling
Managing Editor
Stacey Cuozzo
Production Editor
Terri Gelfand
Sr. Editorial Coordinator
Lisa Katz
Creative Director
Jeannine Coronna
Publishing Operations Director
Beth Scholz
Publisher
Melissa Warner
Group Vice President/General Manager
Recent Videos
According to Jorge Nieva, MD, there are a multitude of things that can be explored to enhance the treatment landscape for lung cancer.
5 experts are featured in this series
2 experts are featured in this series.
5 experts are featured in this series
2 experts are featured in this series.
Taletrectinib showed improved efficacy in patients with ROS1-positive non–small cell lung cancer who were treatment-naïve.
“It’s a drug that I’m very comfortable with, and it is a drug I’ll likely use primarily in the first-line setting,” stated Jorge Nieva, MD, on taletrectinib in non–small cell lung cancer.
4 experts in this video
4 experts in this video
Those being treated for peritoneal carcinomatosis may not have to experience the complication rates or prolonged recovery associated with surgical options.
Related Content